Is Predictive Toxicology the Fast Track to Safe Drugs?
Unexpected toxicity is the single biggest cause of pipeline attrition. Dr. Thomas Steger-Hartmann, Head of Investigational Toxicology at Bayer Healthcare, spoke to Andrea Charles from Pharma IQ, about the strategies medicinal chemists are increasingly attempting to avoid toxicological risk and how companies are enhancing their prediction capabilities. Steger-Hartmann also gives us an insider's view on how the Innovative Medicines Initiative (IMI) is working to speed up t...
TO READ THE FULL STORY
Please note: That all fields marked with an asterisk (*) are required.